Suboxone | Addiction Professional Magazine Skip to content Skip to navigation

Suboxone

Medical director's refrain to patients: 'I don't want to go to your funeral'

September 21, 2018  |  Gary A. Enos, Editor
article
The Mountainside treatment facility in Connecticut is making early inroads with injectable buprenorphine as another option for blocking patients' opioid receptors.

Data show too few youths receive medication for opioid use disorders

September 11, 2018  |  Gary A. Enos, Editor
news
A new study indicates that only about one in four young people with opioid use disorders receives one of the approved medications as part of treatment.

NCAD: Opioid treatment initiative for youths combines three strategies

August 21, 2018  |  Gary A. Enos, Editor
article
The federally supported Project ASSERT in Connecticut is testing several research-based interventions for young people with opioid use disorders, including medication-assisted treatment.

Study: Methadone, buprenorphine after overdose improve survival rates

July 10, 2018  |  Alison Knopf, Contributing Writer
article
A Massachusetts study found that opioid overdose survivors who received methadone or buprenorphine following an overdose showed reduced deaths from subsequent overdoses.

Timing uncertain on introduction of generic Suboxone film

June 18, 2018  |  Gary A. Enos, Editor
news
Two companies have received federal approval to market generic versions of Suboxone film, but ongoing patent litigation could slow their arrival to the market.

Separate unit for opioid disorder treatment builds fellowship

May 7, 2018  |  Gary A. Enos, Editor
article
Caron Treatment Centers responded to patient concerns about isolation by establishing a treatment unit devoted exclusively to opioid use disorders.

Study explores challenge of initiating patient on injectable naltrexone

April 17, 2018  |  Gary A. Enos, Editor
article
New research offers hope for those who might assume it is too difficult to transition an opioid-dependent patient to injectable naltrexone in a community-based setting.

First non-opioid to treat withdrawal clears key hurdle

April 13, 2018  |  Alison Knopf, Contributing Writer
article
An advisory committee to the Food and Drug Administration (FDA) is recommending approval of lofexidine, which would offer an alternative to opioid medications for treatment of opioid withdrawal symptoms.

SAMHSA grants will encourage wider access to naloxone

April 12, 2018  |  Gary A. Enos, Editor
news
Methadone treatment programs and buprenorphine prescribers are among those eligible for federal grants to encourage wider distribution of opioid overdose reversal drugs.

Respect, not coddling, for buprenorphine patients

April 11, 2018  |  Sylvester Sviokla, MD
article
A physician in recovery sees patients soar with an assist from buprenorphine.

Conference highlights Connecticut's pacesetting medication treatment in prisons

March 14, 2018  |  Gary A. Enos, Editor
article
A plenary session at the conference of the American Association for the Treatment of Opioid Dependence (AATOD) featured a look at signs of progress in the correctional and insurance arenas.

No time for petty conflict amid an opioid crisis

March 12, 2018  |  Gary A. Enos, Editor
article
The opening session of the American Association for the Treatment of Opioid Dependence (AATOD) conference emphasized putting to rest old internal conflicts about treatment.

Pages

Subscribe to Suboxone